ABCA1	ATP-binding cassette transporter A1
AD	Alzheimer’s disease
ApoA	Apolipoprotein A
ApoA-I	Apolipoprotein A-I
ApoA-II	Apolipoprotein A-II
ApoA-IV	Apolipoprotein A-IV
ApoA-V	Apolipoprotein A-V
ApoE	Apolipoprotein E
BBB	Blood–brain barrier
CAA	Cerebral amyloid angiopathy
CIDP	Chronic inflammatory demyelinating polyneuropathy
CNS	Central nervous system
CSF	Cerebrospinal fluid
DHCR24	24-dehydrocholesterol reductase
ER	Endoplasmic reticulum
FTD	Frontotemporal dementia
GBS	Guillain-Barré syndrome
GWAS	Genome-wide association study
HDL	High-density lipoprotein
HDL-C	High-density lipoprotein cholesterol
IFN-γ	Interferon-gamma
IL	Interleukin
JAK2/STAT3	Janus kinase 2/signal transducer and activator of transcription 3
LCAT	Lecithin-cholesterol acyltransferase
LDL	Low-density lipoprotein
LDLR	Low-density lipoprotein receptor
LPL	Lipoprotein lipase
MPO	Myeloperoxidase
MS	Multiple sclerosis
N	Number of people (Sample Size)
NF-κB	Nuclear factor kappa-light-chain-enhancer of activated B cells
NRF2/SLC7A11/GSH	Nuclear factor erythroid 2-related factor 2/solute carrier family 7 member 11/glutathione
PD	Parkinson’s disease
PGI2	Prostacyclin
PI3K/Akt	Phosphoinositide 3-kinase/protein kinase B
PPARγ	Peroxisome proliferator-activated receptor gamma
RCT	Reverse cholesterol transport
ROS	Reactive oxygen species
RRMS	Relapsing-remitting multiple sclerosis
S1P	Sphingosine-1-phosphate
SCZ	Schizophrenia
SNP	Single nucleotide polymorphism
SR-B1	Scavenger Receptor Class B type 1
TG	Triglycerides
TLR4	Toll-like receptor 4
TNF-α	Tumor necrosis factor-alpha
VCAM1	Vascular cell adhesion molecule 1
VLDL	Very low-density lipoprotein